Company Profile

Accelevir Diagnostics LLC
Profile last edited on: 10/21/2021      CAGE: 7FL22      UEI: F6SKM7YHCUS7

Business Identifier: Assays for latent HIV
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

855 North Wolfe Street Suite B
Baltimore, MD 21205
   (417) 766-1246
Location: Single
Congr. District: 07
County: Baltimore City

Public Profile

Spun out of Johns Hopkins, Accelevir Diagnostics is developing new assays for latent HIV. More than 35 million people are living the HIV/AIDS. Current antiretroviral drugs halt, but do not eliminate the virus in people who are infected. Instead, HIV persists in a quiescent, or latent form. New therapeutics are being developed to eliminate this latent virus with the goal of curing the infection: creating innovative assays and technologies to support this therapeutic development effort.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency